ForeverLabs
0%
ClinicalBloodAutoimmune Disorders

Hematopoietic stem cell transplantation in autoimmune disorders: From immune-regulatory processes to clinical implications

Science Direct

Key Findings

In certain autoimmune diseases AHSCT can be good choice when conventional therapy failed..

AI generated image for: Hematopoietic stem cell transplantation in autoimmune disorders: From immune-regulatory processes to clinical implications

In certain autoimmune diseases AHSCT can be good choice when conventional therapy failed.

Research Details

Source

Science Direct

Publication Date
Categories & Tags
ClinicalBloodAutoimmune Disorders
View Original Publication

Cite this article: Science Direct. "Hematopoietic stem cell transplantation in autoimmune disorders: From immune-regulatory processes to clinical implications". Published August 11, 2025. Available at: https://www.sciencedirect.com/science/article/abs/pii/S1568997217301441

Access Original Research

View the complete study and detailed methodology from the original source.

Read Full Study↗
← All Articles← Clinical Articles

You Might Also Like

Explore more articles in this category

AI generated image for: Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial
1 min

Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial

This phase II randomized trial demonstrates that autologous hematopoietic stem cell transplantation (AHSCT) is significantly more effective than mitoxantrone at reducing MRI-detected disease activity in patients with aggressive multiple sclerosis. Results showed a 79% reduction in new T2 lesions and a significant decrease in relapse rates, supporting the need for larger phase III clinical trials.

Neurology
AI generated image for: Effect of aging on stem cells
1 min

Effect of aging on stem cells

As we age, stem cells lose efficacy and ability to heal.

NIH
AI generated image for: Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer's disease
1 min

Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer's disease

Intravenous transplantation of bone marrow-derived mononuclear cells (BMMCs) successfully improved cognitive function and prevented neurodegeneration in two different Alzheimer's disease mouse models.

PubMed